The risk of multiple primary breast and thyroid carcinomas: Role of the radiation dose

Cancer

Volumn 98, Issue 6, 2003, Pages 1309-1317

  Adjadj, Élisabeth ^a   Rubino, Carole ^a   Shamsaldim, Akhtar ^a   Lê, Monique G ^a   Schlumberger, Martin ^a   De Vathaire, Florent ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Breast carcinoma; Radiation carcinogenesis; Radiotherapy; Second malignant neoplasm; Thyroid carcinoma

Indexed keywords

IODINE 131;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; BREAST CARCINOMA; CANCER RADIOTHERAPY; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSIMETRY; FEMALE; HUMAN; IONIZING RADIATION; MAJOR CLINICAL STUDY; MULTIPLE CANCER; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; RADIATION HAZARD; RADIOISOTOPE THERAPY; RISK ASSESSMENT; THYROID CARCINOMA;

ADOLESCENT; ADULT; AGED; BRACHYTHERAPY; BREAST NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY DOSAGE; THYROID NEOPLASMS;

EID: 0042918062     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11626     Document Type: Article

References (40)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC cancer base no. 5. Lyon: IARC Press, 2001. Available from URL. http//www-dep.iarc.fr/globocan/ globocan.html [accessed 11 October 2002].
2. Ron E, Curtis R, Hoffman DA, Flannery JT. Multiple primary breast and thyroid cancer. Br J Cancer. 1984;49:87-92.
3. Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut, 1935-1982. Natl Cancer Inst Monogr. 1985;68:99-112.
4. McTiernan A, Weiss NS, Daling JR. Incidence of thyroid cancer in women in relation to known or suspected risk factors for breast cancer. Cancer Res. 1987;47:292-295.
5. Murakami R, Hiyama T, Hanai A, Fujimoto I. Second primary cancers following female breast cancer in Osaka, Japan - a population-based cohort study. Jpn J Clin Oncol. 1987;17:293-302.
6. Hrafnkelsson J, Tulinius H, Jonasson JG, Olafsdottir G, Sigvaldason H. Papillary thyroid carcinoma in Iceland. A study of the occurrence in families and the coexistence of other primary tumours. Acta Oncol. 1989;28:785-788.
7. Stein M, Bartal A, Kuten A, et al. Multiple primary thyroid and breast cancer in Israel, 1960-1976. South Afr Med J. 1989;76:664-666.
8. Volk N, Pompe-Kirn V. Second primary cancers in breast cancer patients in Slovenia. Cancer Causes Control. 1997;8: 764-770.
9. Vassilopoulou-Sellin R, Palmer L, Taylor S, Cooksley CS. Incidence of breast carcinoma in women with thyroid carcinoma. Cancer. 1999;85:696-705.
10. Li CI, Rossing MA, Voigt LF, Daling JR. Multiple primary breast and thyroid cancers: role of age at diagnosis and cancer treatment (United States). Cancer Causes Control. 2000;11:805-811.
11. Chen AY, Levy L, Goepfert H, Brown BW, Spitz MR, Vassilopoulou-Sellin R. The development of breast carcinoma in women with thyroid carcinoma. Cancer. 2001;92:225-231.
12. Tanaka H, Tsukuma H, Koyama H, Kinoshita Y, Kinoshita N, Oshima A. Second primary cancers following breast cancer in the Japanese female population. Jpn I Cancer Res. 2001; 92:1-8.
13. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. New York: United Nations, 2000.
14. Huang J, Walker R, Groome PG, Shelley W, Mackillop WJ. Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma. Cancer. 2001;92:1411-1418.
15. de Vathaire F, Schlumberger M, Delisle MJ, et al. Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer. 1997;75: 734 -739.
16. Diallo I, Lamon A, Shamsaldim A, Grimaud E, de Vathaire F, Chavaudra J. Estimation of the radiation dose delivered at any point in the body for individual patients in external beam radiotherapy. Radiother Oncol. 1996;38:269-271.
17. Shamsaldim A, Grimaud E, Hardiman C, Diallo I, de Vathaire F, Chavaudra J. Dose distribution throughout the body for radiotherapy for Hodgkin's disease in childhood Radiother Oncol. 1998;49:85-90.
18. Cade S, Carling ER. Malignant disease and its treatment by radium. Bristol: John Wright & Sons Ltd., 1948.
19. Ligot L, Diallo I, Shamsaldin A, Chavaudra J, Bonaiti-Pellie C, de Vathaire F. Individualized phantom based on CT slices and auxological data (ICTA) for dose estimations following radiotherapy for skin haemangioma in childhood. Radiother Oncol. 1998;49:279-285.
20. Shamsaldin A, Lundell M, Diallo I, Ligot L, Chavaudra J, de Vathaire F. Estimation of the radiation dose from radiotherapy for skin haemangiomas in childhood: the ICTA software for epidemiology. Phys Med Biol. 2000;45:3589-3599.
21. International Commission on Radiological Protection (ICRP). Radiation dose to patients from radiopharmaceuticals, ICRP publication 53. Oxford: Pergamon Press, 1988.
22. Moolgavkar SH, Venzon DJ. A method for computing profile likelihood based confidence bounds. Ann Stat. 1987;15:346-359.
23. Menegoz F, Cherié-Challine L. Le cancer en France: incidence et mortalité. Situation en 1995. Evolution entre 1975 et 1995. Paris: La Documentation Française, 1998.
24. Preston DL, Lubin JH, Pierce DA, McConney ME. EPICURE. Generalized regression models for epidemiological data. Seattle: Hirosoft International Corporation, 1991.
25. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors, 5th edition. New York: John Wiley & Sons, 1997.
26. Tazebay UH, Wapnir IL, Levy O, et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med. 2000;6:871-878.
27. Mattsson A, Ruden BI, Palmgren J, Rutqvist LE. Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease. Br J Cancer. 1995;72:1054-1061.
28. Hall P, Holm LE, Lundell G, Ruden BI. Tumors after radiotherapy for thyroid cancer. A case-control study within a cohort of thyroid cancer patients. Acta Oncol. 1992;31:403-407.
29. Clavel-Chapelon F, Gerber M. Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis? Breast Cancer Res Treat. 2002;72:107-115.
30. Negri E, Dal Maso L, Ron E, et al. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control. 1999;10:143-155.
31. Rossing MA, Voigt LF, Wicklund KG, Daling JR. Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol. 2000;151:765-772.
32. Simon MS, Tang MT, Bernstein L, et al. Do thyroid disorders increase the risk of breast cancer? Cancer Epidemiol Biomarkers Prev. 2002;11:1574-1578.
33. Giani C, Fierabracci P, Bonacci IR, et al. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab. 1996;81:990-994.
34. Smyth PP, Smith DF, McDermott EW, Murray MJ, Geraghty JG, O'Higgins NJ. A direct relationship between thyroid enlargement and breast cancer. J Clin Endocrinol Metab. 1996; 81:937-941.
35. Shering SG, Zbar AP, Moriarty M, McDermott EW, O'Higgins NJ, Smyth PP. Thyroid disorders and breast cancer. Eur J Cancer Prev. 1996;5:504-506.
36. Dalla Valle L, Ramina A, Vianello S, Fassina A, Belvedere P, Colombo L. Potential for estrogen synthesis and action in human normal and neoplastic thyroid tissues. J Clin Endocrinol Metab. 1998;83:3702-3709.
37. Weiss M, Zaretsky J, Zimlichman J, et al. Expression of a gene coding for breast tumor-associated antigen in thyroid papillary carcinoma. Cancer Lett. 1991;58:125-130.
38. Silva JM, Dominguez G, Gonzalez-Sancho JM, et al. Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer. Oncogene. 2002;21:4307-4316.
39. Puzianowska-Kuznicka M, Krystyniak A, Madej A, Cheng SY, Nauman J. Functionally impaired TR mutants are present in thyroid papillary cancer. J Clin Endocrinol Metab. 2002;87: 1120-1128.
40. Portella G, Salvatore D, Botti G, et al. Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene. Oncogene. 1996;13:2021-2026.